199 related articles for article (PubMed ID: 27080237)
1. Stratification of Digestive Cancers with Different Pathological Features and Survival Outcomes by MicroRNA Expression.
Tang S; Wu WK; Li X; Wong SH; Wong N; Chan MT; Sung JJ; Yu J
Sci Rep; 2016 Apr; 6():24466. PubMed ID: 27080237
[TBL] [Abstract][Full Text] [Related]
2. Small RNA expression from viruses, bacteria and human miRNAs in colon cancer tissue and its association with microsatellite instability and tumor location.
Mjelle R; Sjursen W; Thommesen L; Sætrom P; Hofsli E
BMC Cancer; 2019 Feb; 19(1):161. PubMed ID: 30786859
[TBL] [Abstract][Full Text] [Related]
3. The Impact of MicroRNA-133a on Prognosis and Clinicopathological Parameters for Digestive System Cancers: a Comprehensive Study Based on Meta-Analysis and TCGA Database.
Zhu W; Ji X
Pathol Oncol Res; 2020 Apr; 26(2):771-781. PubMed ID: 30810894
[TBL] [Abstract][Full Text] [Related]
4. A Cluster-Based Approach for Identifying Prognostic microRNA Signatures in Digestive System Cancers.
Zhou J; Cui X; Xiao F; Cai G
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33546390
[TBL] [Abstract][Full Text] [Related]
5. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.
Ahmed FE; Ahmed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Mota H; Allison RR
Cancer Genomics Proteomics; 2013; 10(3):93-113. PubMed ID: 23741026
[TBL] [Abstract][Full Text] [Related]
7. Splicing-dependent expression of microRNAs of mirtron origin in human digestive and excretory system cancer cells.
Butkytė S; Čiupas L; Jakubauskienė E; Vilys L; Mocevicius P; Kanopka A; Vilkaitis G
Clin Epigenetics; 2016; 8():33. PubMed ID: 27019673
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of MicroRNA-19b predicts good prognosis in patients with hepatocellular carcinoma presenting with vascular invasion or multifocal disease.
Hung CL; Yen CS; Tsai HW; Su YC; Yen CJ
BMC Cancer; 2015 Oct; 15():665. PubMed ID: 26453548
[TBL] [Abstract][Full Text] [Related]
9. Identification of new aberrantly expressed miRNAs in intestinal-type gastric cancer and its clinical significance.
Li X; Luo F; Li Q; Xu M; Feng D; Zhang G; Wu W
Oncol Rep; 2011 Dec; 26(6):1431-9. PubMed ID: 21874264
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA expression profiles predict clinical phenotypes and prognosis in chromophobe renal cell carcinoma.
Ge YZ; Xin H; Lu TZ; Xu Z; Yu P; Zhao YC; Li MH; Zhao Y; Zhong B; Xu X; Zhou LH; Wu R; Xu LW; Wu JP; Li WC; Zhu JG; Jia RP
Sci Rep; 2015 May; 5():10328. PubMed ID: 25981392
[TBL] [Abstract][Full Text] [Related]
11. A microRNA expression signature as a predictor of survival for colon adenocarcinoma.
Xu M; Kuang Y; Wang M; Han X; Yang Q
Neoplasma; 2017; 64(1):56-64. PubMed ID: 27881005
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R
Int J Cancer; 2013 Apr; 132(7):1633-45. PubMed ID: 22987275
[TBL] [Abstract][Full Text] [Related]
13. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
Wang B; Li J; Sun M; Sun L; Zhang X
IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313
[TBL] [Abstract][Full Text] [Related]
14. Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy.
Drebber U; Lay M; Wedemeyer I; Vallböhmer D; Bollschweiler E; Brabender J; Mönig SP; Hölscher AH; Dienes HP; Odenthal M
Int J Oncol; 2011 Aug; 39(2):409-15. PubMed ID: 21567082
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA markers for the diagnosis of pancreatic and biliary-tract cancers.
Kojima M; Sudo H; Kawauchi J; Takizawa S; Kondou S; Nobumasa H; Ochiai A
PLoS One; 2015; 10(2):e0118220. PubMed ID: 25706130
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations.
Ladeiro Y; Couchy G; Balabaud C; Bioulac-Sage P; Pelletier L; Rebouissou S; Zucman-Rossi J
Hepatology; 2008 Jun; 47(6):1955-63. PubMed ID: 18433021
[TBL] [Abstract][Full Text] [Related]
18. Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma.
Li LM; Hu ZB; Zhou ZX; Chen X; Liu FY; Zhang JF; Shen HB; Zhang CY; Zen K
Cancer Res; 2010 Dec; 70(23):9798-807. PubMed ID: 21098710
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA expression patterns of tumors in early-onset colorectal cancer patients.
Ak S; Tunca B; Tezcan G; Cecener G; Egeli U; Yilmazlar T; Ozturk E; Yerci O
J Surg Res; 2014 Sep; 191(1):113-22. PubMed ID: 24746948
[TBL] [Abstract][Full Text] [Related]
20. MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma.
Lin RJ; Xiao DW; Liao LD; Chen T; Xie ZF; Huang WZ; Wang WS; Jiang TF; Wu BL; Li EM; Xu LY
J Surg Oncol; 2012 Feb; 105(2):175-82. PubMed ID: 21882196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
